XOMA Corp (NASDAQ:XOMA)
| 4.13 Data as of May 23 |  +0.17 / +4.29%Today’s Change | 2.25 Today|||52-Week Range 4.40 | +72.08% Year-to-Date |
Latest XOMA News | Press Releases
No recent news for XOMA Corp.
Today’s Trading
| Previous close | 3.96 |
| Today’s open | 3.90 |
| Day’s range | 3.77 - 4.13 |
| Volume | 700,855 |
| Average volume (3 months) | 681,837 |
| Market cap | $328.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -5.77% |
| Earnings growth (this year) | +25.29% |
| Earnings growth (next 5 years) | +36.00% |
| Revenue growth (last year) | -41.95% |
| P/E ratio | NM |
| Price/Sales | 4.59 |
| Price/Book | 15.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TXMDTherapeuticsMD Inc | -0.19 | -7.22% |
| LCILannett Company Inc | +0.62 | +5.15% |
| THLDThreshold Pharmaceut... | +0.19 | +3.49% |
| VICLVical Inc | +0.07 | +1.99% |
Data as of 4:01pm ET, 05/23/2013
Financials
| Next reporting date | August 12, 2013 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $33.8M |
| Annual profit (last year) | -$71.1M |
| Net profit margin | -210.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director John W. Varian |
Chief Financial Officer & Vice President Fred Kurland, MBA |
Corporate headquarters Berkeley, California |
Forecasts
